Lixin Zhang

No ORCID on file · 20 papers in corpus · active 2014-2026

Study types

  • preprint 18
  • article 1
  • other 1

Condition tags

  • endometriosis 20
  • infertility 1
other 2026
Iron dysmetabolism in ovarian follicles: implications for oocyte quality and embryo development in endometriosis
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2025.105215

RESEARCH QUESTION: Do iron metabolism and ferroptosis influence oocyte and embryo quality in patients with endometriosis undergoing IVF/intracytoplasmic sperm injection (ICSI), or in a mouse model? DESIGN: Fifty-seven patients with laparos…

preprint 2023
Data from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.c.6522953.v1

AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …

preprint 2023
Data from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.c.6522953

AbstractPurpose: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian …

preprint 2023
Supplementary Materials and Methods from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455170.v1

Supplementary Materials and Methods

preprint 2023
Supplementary Materials and Methods from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455170

Supplementary Materials and Methods

preprint 2023
Suppl Fig S1 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455191

Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons

preprint 2023
Suppl Fig S1 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455191.v1

Suppl Fig S1. Venn diagram of DE genes from 3 group comparisons

preprint 2023
Suppl Fig S2 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455188.v1

Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression

preprint 2023
Suppl Fig S2 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455188

Suppl Fig S2. Kras and Pten pathways in relationship to complement gene expression

preprint 2023
Suppl Fig S3 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455185.v1

Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity

preprint 2023
Suppl Fig S3 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455185

Suppl Fig S3. Antibody-mediated, complement-induced cytotoxicity

preprint 2023
Suppl Fig S4 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455182

Suppl Fig S4. Complement and non-target siRNA

preprint 2023
Suppl Fig S4 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455182.v1

Suppl Fig S4. Complement and non-target siRNA

preprint 2023
Suppl Table S1 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455179.v1

Suppl Table S1. Differentially expressed genes from different group comparisons

preprint 2023
Suppl Table S1 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455179

Suppl Table S1. Differentially expressed genes from different group comparisons

preprint 2023
Suppl Table S2 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455176

Suppl Table S2. Top five canonical pathways from different group comparisons, identified via Ingenuity Pathway Analyses

preprint 2023
Suppl Table S2 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455176.v1

Suppl Table S2. Top five canonical pathways from different group comparisons, identified via Ingenuity Pathway Analyses

preprint 2023
Suppl Table S3 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455173

Suppl Table S3. Top five networks from different group comparisons, identified via Ingenuity Pathway Analyses

preprint 2023
Suppl Table S3 from Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
·doi:10.1158/1078-0432.22455173.v1

Suppl Table S3. Top five networks from different group comparisons, identified via Ingenuity Pathway Analyses

article 2014
Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-14-1338

PURPOSE: Mechanisms of immune dysregulation associated with advanced tumors are relatively well understood. Much less is known about the role of immune effectors against cancer precursor lesions. Endometrioid and clear-cell ovarian tumors p…